StartupsSiftedabout 10 hours ago
Orakl Oncology Raises $34M Series A
3 min read
Paris-based startup Orakl Oncology raised $34 million in a Series A round led by Norrsken and Singular. CEO Dr. Fanny Jaulin leads the team building AI virtual patients to test drugs. Total funding reaches $50 million since 2023 founding.
Level
Hype check
Tap to vote and see what everyone thinks.
